GNOM - Global X Genomics & Biotechnology UCITS ETF (USD) (Acc) (IE00BM8R0N95)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Sélectionnez tout Réinitialiser tout

Enregistrer Fermer

(%)

IE00BM8R0N95

GNOM ISIN

Fonds négociés en bourse (FNB)

Type de fonds

Mirae Asset Global Investments

Fournisseur

valeur liquidative par action

02/11/2021

Date de lancement

Non

Paiement de dividendes

CEOGES

CFI

GNOM

Ticker

Formed

Status

Equity

Objet d'investissement

Healthcare

Secteur

Global

Géographie

Solactive Genomics v2 Index

Benchmark

0.5 %

Ratio de coût total

Physical

Méthode de réplication

Oui

UCITS

Dernières données pour

Ajouter à comparer

Cotations (GNOM)

Explorer la base de données la plus complète

1 000 000

obligations

80 234

actions

167 970

ETF & Funds

80 000

indices

Suivre votre portefeuille de la manière la plus efficace

Screener d'obligations
liste de surveillance
Excel ADD-IN

Obtenir l'accès

Dynamique des prix

Fund profile

The Global X Genomics & Biotechnology UCITS ETF seeks to replicate as close as possible the performance of the Solactive Genomics v2 Index investing in companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology.

GNOM profile

The Global X Genomics & Biotechnology UCITS ETF (USD) (Acc) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The Mirae Asset Global Investments fund’s base currency is USD and the share class was registered 02.11.2021 with unique ISIN - IE00BM8R0N95. Main exchange is London S.E. (USD) and ticker symbol is GNOM. The total expense ratio is 0.5%. The Global X Genomics & Biotechnology UCITS ETF (USD) (Acc) pays dividends 0 time(s) per year.

Structure GNOM au 01/04/2026

Exporter la structure dans Excel

Titre	Valeur
MODERNA INC	8,25%
PRAXIS PRECISION MEDICINES I	6,64%
ARROWHEAD PHARMACEUTICALS IN	6,36%
ILLUMINA INC	5,43%
GUARDANT HEALTH INC	5,14%
BIOMARIN PHARMACEUTICAL INC	4,49%
VERTEX PHARMACEUTICALS INC	4,36%
NATERA INC	4,29%
BIONTECH SE-ADR	3,52%
BIO-TECHNE CORP	3,51%
QIAGEN N.V.	3,31%
CRISPR THERAPEUTICS AG	3,18%
BRISTOL-MYERS SQUIBB CO	2,92%
ALNYLAM PHARMACEUTICALS INC	2,78%
TWIST BIOSCIENCE CORP	2,73%
ASTRAZENECA PLC	2,45%
LEGEND BIOTECH CORP-ADR	2,41%
GILEAD SCIENCES INC	2,41%
ELI LILLY & CO	2,39%
VERACYTE INC	2,38%
10X GENOMICS INC-CLASS A	2,32%
BEAM THERAPEUTICS INC	2,11%
SAREPTA THERAPEUTICS INC	1,95%
ULTRAGENYX PHARMACEUTICAL IN	1,83%
GENSCRIPT BIOTECH CORP	1,61%
GENEDX HOLDINGS CORP	1,58%
INTELLIA THERAPEUTICS INC	1,29%
UNIQURE NV	0,88%
CAREDX INC	0,86%
WAVE LIFE SCIENCES LTD	0,83%
VIR BIOTECHNOLOGY INC	0,77%
AGILENT TECHNOLOGIES INC	0,41%
MYRIAD GENETICS INC	0,39%
REGENXBIO INC	0,38%
MESA LABORATORIES INC	0,35%
PACIFIC BIOSCIENCES OF CALIF	0,34%
PERSONALIS INC	0,31%
FULGENT GENETICS INC	0,29%
STOKE THERAPEUTICS INC	0,29%
MARAVAI LIFESCIENCES HLDGS-A	0,29%
PRIME MEDICINE INC	0,28%
ROCKET PHARMACEUTICALS INC	0,27%
EDITAS MEDICINE INC	0,25%
CARIBOU BIOSCIENCES INC	0,24%
ARCTURUS THERAPEUTICS HOLDIN	0,24%
STANDARD BIOTOOLS INC	0,24%
SANA BIOTECHNOLOGY INC	0,16%
SANGAMO THERAPEUTICS INC	0,13%
BRITISH STERLING POUND	0,1%
ATRIUM THERAPEUTICS INC	0,08%
CASH	0,01%
HONG KONG DOLLAR	0%
EURO	0%
OTHER PAYABLE & RECEIVABLES	-0,02%

Montrer tout Cacher

Autres - %

Autres ETF et fonds de ce fournisseur

ETF et fonds similaires

{{ item.etf.ttl }}

{{ item.nav_usd }} mln
Valeur nette d'actifs

{{ item.expense_ratio }}
Ratio de coût total